NCT04443283

Brief Summary

This study evaluate the effect of latent infection of tuberculosis on the pregnancy outcome of IVF-ET in infertile patients with radiographic lesions suggesting old healed tuberculosis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

June 21, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 23, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

June 29, 2020

Status Verified

March 1, 2020

Enrollment Period

4 years

First QC Date

June 21, 2020

Last Update Submit

June 25, 2020

Conditions

Keywords

infertilityIVF-ETold tuberculosispregnancy outcomelatent tuberculosis infection

Outcome Measures

Primary Outcomes (3)

  • clinical pregnancy rate

    Clinical pregnancy was defined as the observation of a gestational sac on ultrasonography. The clinical pregnancy rate was defined as clinical pregnancy per embryo transfer.

    30 days after the ET procedure

  • miscarriage rate

    Miscarriage was defined as a pregnancy loss before 28 weeks of gestation (calculated among women who became pregnant). The miscarriage rate was defined as miscarriages per clinical pregnancy.

    40 weeks after the ET procedure

  • live birth rate

    Live birth was defined as delivery of a living foetus (or living foetuses) beyond 28 weeks of gestation. The live birth rate was defined as live birth per embryo transfer.

    40 weeks after the ET procedure

Secondary Outcomes (1)

  • tuberculosis reactivation

    40 weeks after the ET procedure

Study Arms (2)

LTBI Group

IGRA(+)

Other: No intervention

No LTBI Group

IGRA(+)

Other: No intervention

Interventions

This is a observation study, with no intervention

LTBI GroupNo LTBI Group

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants were recruited between January 1, 2019, and December 30, 2020, at Peking University Third Hospital, a tertiary referral hospital in Beijing, China. A board-certified radiologist reviewed CXRs and, if available, chest computed tomography (CT) scans, of women who referred to the reproductive center for IVF-ET. The patients who had chest imaging abnormalities consistent with old healed TB were admitted or referred to the respiratory clinic and enrolled.

You may qualify if:

  • The patients who referred to the reproductive center for IVF-ET
  • Chest radiography showed old healed tuberculosis

You may not qualify if:

  • active tuberculosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

Related Publications (1)

  • Gai X, Chi H, Zeng L, Cao W, Chen L, Zhang C, Li R, Sun Y, Qiao J. Impact of Positive Interferon-Gamma Release Assay on IVF-ET Pregnancy Outcomes in Infertile Patients With Untreated Prior Tuberculosis: A Prospective Cohort Study. Front Med (Lausanne). 2021 Nov 16;8:749410. doi: 10.3389/fmed.2021.749410. eCollection 2021.

Biospecimen

Retention: SAMPLES WITHOUT DNA

collect seum sample to detect some inflammatory factors

MeSH Terms

Conditions

InfertilityTuberculosisLatent Tuberculosis

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsLatent Infection

Study Officials

  • Ji Qiao, MD.

    Reproductive Medicine Centre,Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2020

First Posted

June 23, 2020

Study Start

January 1, 2019

Primary Completion

December 30, 2022

Study Completion

December 30, 2022

Last Updated

June 29, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations